- Home
- / Fuji Pharma
Fuji Pharma
Stock Price
¥1.3 K
2024-10-29
Market Capitalization
¥32.1 B
2024-10-29
Revenue
¥51.7 B
FY, 2025
Fuji Pharma Summary
Company Summary
- Overview
- Fuji Pharma (富士製薬工業) is a pharmaceutical company. It develops, manufactures, and merchandises pharmaceuticals, such as injection agents, internal drugs, drugs for external use, and diagnostic products.
- Type
- Public
- Status
- Active
- Founded
- 1965
- HQ
- Chiyoda, JP | view all locations
- Website
- http://www.fujipharma.jp
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
2 locations detected
Chiyoda, Tokyo HQ
Japan
5-7 Sanbanchō
Kyoto
Japan
Hokkaido-tohoku, Kanto First, Kanto Second
Fuji Pharma Financials
Summary Financials
- Revenue (Q2, 2026)
- ¥13.8B
- Gross profit (Q2, 2026)
- ¥6.6B
- Net income (Q2, 2026)
- ¥389.0M
- Cash (Q2, 2026)
- ¥10.9B
- EBIT (Q2, 2026)
- ¥1.7B
- Enterprise value
- $50.8B